1887

Abstract

Genetic variants of have been reported with increasing frequency, but their true incidence is unknown. strains have been classified into variant toxinotypes according to variations in the pathogenicity locus encoding the major virulence factors, toxins A and B. Some strains produce an additional toxin, binary toxin CDT. This survey of clinical isolates (153) from patients in a single hospital set out to ascertain the distribution of variant toxinotypes and strains possessing binary toxin genes. A PCR-RFLP-based method of toxinotyping identified 123 (80.4 %) isolates as toxinotype 0, 13 (8.5 %) strains as non-toxigenic and 17 (11.1 %) as belonging to variant toxinotypes. Binary toxin genes were amplified by PCR in nine strains (5.8 %), all of which were variant toxinotypes. Toxin variants of are pathogenic and commonly isolated and need to be considered when evaluating new diagnostic testing strategies for disease.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45610-0
2004-09-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/53/9/JM530909.html?itemId=/content/journal/jmm/10.1099/jmm.0.45610-0&mimeType=html&fmt=ahah

References

  1. al-Barrak, A., Embil, J., Dyck, B., Olekson, K., Nicoll, D., Alfa, M. & Kabani, A. ( 1999;). An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 25, 65–69.
    [Google Scholar]
  2. Barbut, F., Richard, A., Hamadi, K., Chomette, V., Burghoffer, B. & Petit, J.-C. ( 2000;). Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38, 2386–2388.
    [Google Scholar]
  3. Barbut, F., Lalande, V., Burghoffer, B., Thien, H. V., Grimprel, E. & Petit, J. C. ( 2002;). Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 40, 2079–2083.[CrossRef]
    [Google Scholar]
  4. Bélanger, S. D., Boissinot, M., Clairoux, N., Picard, F. J. & Bergeron, M. G. ( 2003;). Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol 41, 730–734.[CrossRef]
    [Google Scholar]
  5. Braun, V., Hundsberger, T., Leukel, P., Sauerborn, M. & von Eichel-Streiber, C. ( 1996;). Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181, 29–38.[CrossRef]
    [Google Scholar]
  6. Braun, V., Mehlig, M., Moos, M., Rupnik, M., Kalt, B., Mahony, D. E. & von Eichel-Streiber, C. ( 2000;). A chimeric ribozyme in Clostridium difficile combines features of group I introns and insertion elements. Mol Microbiol 36, 1447–1459.
    [Google Scholar]
  7. Brazier, J. S., Stubbs, S. L. & Duerden, B. I. ( 1999;). Prevalence of toxin A negative/B positive Clostridium difficile strains. J Hosp Infect 42, 248–249.
    [Google Scholar]
  8. Camorlinga-Ponce, M., Gamboa, M., Barragan, J. J., Munoz, O., Fekety, F. R. & Torres, J. F. ( 1987;). Epidemiological aspects of Clostridium difficile in a pediatric hospital and its role in diarrheal disease. Eur J Clin Microbiol 6, 542–546.[CrossRef]
    [Google Scholar]
  9. Carman, R., McEllistrem, M. C., Genheimer, C. W. & Zheng, L. ( 2003;). Iota-like binary toxin producing strains of Clostridium difficile (Cd) associated with an outbreak of severe nosocomial antibiotic-associated diarrhea (ADD). In ASM 103rd general meeting abstract book, Washington, DC, abstract C-381, p. 188. Washington, DC: American Society for Microbiology.
  10. Chaves-Olarte, E., Freer, E., Parra, A., Guzman-Verri, C., Moreno, E. & Thelestam, M. ( 2003;). R-ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile. J Biol Chem 278, 7956–7963.[CrossRef]
    [Google Scholar]
  11. Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R. & Gerding, D. N. ( 1992;). Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 166, 561–567.[CrossRef]
    [Google Scholar]
  12. Cohen, S. H., Tang, Y. J., Hansen, B. & Silva, J., Jr ( 1998;). Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C.difficile-associated diarrhea. Clin Infect Dis 26, 410–412.[CrossRef]
    [Google Scholar]
  13. Delmée, M., Verellen, G., Avesani, V. & Francois, G. ( 1988;). Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr 147, 36–40.[CrossRef]
    [Google Scholar]
  14. Depitre, C., Delmée, M., Avesani, V., L'Haridon, R., Roels, A., Popoff, M. & Corthier, G. ( 1993;). Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol 38, 434–441.[CrossRef]
    [Google Scholar]
  15. Geric, B., Rupnik, M., Sambol, S. P., Carman, R. J., Grabnar, M., Gerding, D. N. & Johnson, S. ( 2003a;). The effect of Clostridium difficile binary toxin (CDT) in animals depends upon the animal model. In Program and abstracts of Clostridia Pathogenesis 03, Woods Hole, MA, abstract 12.
  16. Geric, B., Johnson, S., Gerding, D. N., Grabnar, M. & Rupnik, M. ( 2003b;). Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 41, 5227–5232.[CrossRef]
    [Google Scholar]
  17. Hammond, G. A. & Johnson, J. L. ( 1995;). The toxigenic element of Clostridium difficile strain VPI 10463. Microb Pathog 19, 203–213.[CrossRef]
    [Google Scholar]
  18. Johnson, S. & Gerding, D. N. ( 1998;). Clostridium difficile-associated diarrhea. Clin Infect Dis 26, 1027–1036.[CrossRef]
    [Google Scholar]
  19. Johnson, S., Adelmann, A., Clabots, C. R., Peterson, L. R. & Gerding, D. N. ( 1989;). Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 159, 340–343.[CrossRef]
    [Google Scholar]
  20. Johnson, S., Kent, S. A., O'Leary, K. J., Merrigan, M. M., Sambol, S. P., Peterson, L. R. & Gerding, D. N. ( 2001;). Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med 135, 434–438.[CrossRef]
    [Google Scholar]
  21. Kader, H. A., Piccoli, D. A., Jawad, A. F., McGowan, K. L. & Maller, E. S. ( 1998;). Single toxin detection is inadequate to diagnose Clostridium difficile diarrhea in pediatric patients. Gastroenterology 115, 1329–1334.[CrossRef]
    [Google Scholar]
  22. Kato, H., Kato, N., Watanabe, K. & 7 other authors ( 1998;). Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36, 2178–2182.
    [Google Scholar]
  23. Kuijper, E. J., de Weerdt, J., Kato, H., Kato, N., van Dam, A. P., van der Vorm, E. R., Weel, J., van Rheenen, C. & Dankert, J. ( 2001;). Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20, 528–534.[CrossRef]
    [Google Scholar]
  24. Lyerly, D. M., Neville, L. M., Evans, D. T. & 7 other authors ( 1998;). Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J Clin Microbiol 36, 184–190.
    [Google Scholar]
  25. Mekonen, E. T., Gerding, D. N., Sambol, S. P., Pottinger, J. M., Pulvirenti, J. J., Marsh, D., Kocka, F. E. & Johnson, S. ( 2002;). Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitals. Infect Control Hosp Epidemiol 23, 648–652.[CrossRef]
    [Google Scholar]
  26. O'Neill, G. L., Beaman, M. H. & Riley, T. V. ( 1991;). Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 107, 627–635.[CrossRef]
    [Google Scholar]
  27. O'Neill, G. L., Ogunsola, F. T., Brazier, J. S. & Duerden, B. I. ( 1996;). Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2, 205–209.[CrossRef]
    [Google Scholar]
  28. Perelle, S., Gibert, M., Bourlioux, P., Corthier, G. & Popoff, M. R. ( 1997;). Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65, 1402–1407.
    [Google Scholar]
  29. Pituch, H., van den Braak, N., van Leeuwen, W., van Belkum, A., Martirosian, G., Obuch-Woszczatynski, P., Luczak, M. & Meisel-Mikolajczyk, F. ( 2001;). Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect 7, 442–446.[CrossRef]
    [Google Scholar]
  30. Popoff, M. R., Rubin, E. J., Gill, D. M. & Boquet, P. ( 1988;). Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56, 2299–2306.
    [Google Scholar]
  31. Rupnik, M. ( 2001;). How to detect Clostridium difficile variant strains in a routine laboratory. Clin Microbiol Infect 7, 417–420.[CrossRef]
    [Google Scholar]
  32. Rupnik, M., Braun, V., Soehn, F., Janc, M., Hofstetter, M., Laufenberg-Feldmann, R. & von Eichel-Streiber, C. ( 1997;). Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol Lett 148, 197–202.[CrossRef]
    [Google Scholar]
  33. Rupnik, M., Avesani, V., Janc, M., von Eichel-Streiber, C. & Delmée, M. ( 1998;). A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36, 2240–2247.
    [Google Scholar]
  34. Rupnik, M., Brazier, J. S., Duerden, B. I., Grabnar, M. & Stubbs, S. L. ( 2001;). Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 147, 439–447.
    [Google Scholar]
  35. Rupnik, M., Kato, N., Grabnar, M. & Kato, H. ( 2003a;). New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 41, 1118–1125.[CrossRef]
    [Google Scholar]
  36. Rupnik, M., Grabnar, M. & Geric, B. ( 2003b;). Binary toxin producing Clostridium difficile strains. Anaerobe 9, 289–294.[CrossRef]
    [Google Scholar]
  37. Sambol, S. P., Merrigan, M. M., Lyerly, D., Gerding, D. N. & Johnson, S. ( 2000;). Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun 68, 5480–5487.[CrossRef]
    [Google Scholar]
  38. Spigaglia, P. & Mastrantonio, P. ( 2002;). Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40, 3470–3475.[CrossRef]
    [Google Scholar]
  39. Stubbs, S., Rupnik, M., Gibert, M., Brazier, J., Duerden, B. & Popoff, M. ( 2000;). Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186, 307–312.[CrossRef]
    [Google Scholar]
  40. Wilcox, M. H., Fawley, W. N., Settle, C. D. & Davidson, A. ( 1998;). Recurrence of symptoms in Clostridium difficile infection–relapse or reinfection? J Hosp Infect 38, 93–100.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45610-0
Loading
/content/journal/jmm/10.1099/jmm.0.45610-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error